GRCENasdaqPharmaceutical PreparationsFiscal year ends March 31
Grace Therapeutics, Inc.
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$1.88−0.01 (-0.53%)
Close on Oct 19, 2026
- Market cap
- $32.47M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
18.8%
4M of 21M shares
Institutional holders
33
10 new, 11 sold out
Net institutional buying
-0M
In Q2 2026
Insider trades, 12 months
6 buys · 0 sales
Net bought $301.87K
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| AIGH Capital Management LLC | 907,217 | 5.90% | 13G (passive) amendment | Dec 31, 2025 |
| Opaleye Management Inc. | 2,748,392 | 13.07% | 13G (passive) | Aug 5, 2026 |
| Daniel Schneeberger | 1,806,216 | 9.90% | 13G (passive) amendment | Jun 30, 2026 |
| ADAR1 Capital Management GP, LLC | 1,717,426 | 9.90% | 13G (passive) amendment | Mar 31, 2026 |
| Wilmot B. Harkey | 1,404,032 | 9.99% | 13G (passive) amendment | Jun 30, 2025 |
| AIGH Capital Management, LLC | 1,322,379 | 9.90% | 13G (passive) amendment | Mar 31, 2025 |
| Nantahala Capital Management, LLC | 1,178,203 | 6.75% | 13G (passive) amendment | Jun 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of GRCE | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Cerity Partners LLC | 849,055 | 4.04% | $1.93M | – | 0.00% |
| Eversept Partners, LP | 772,900 | 3.67% | $1.75M | +16,300 | 0.09% |
| Bank Of America Corp /De/ | 494,698 | 2.35% | $1.12M | −25 | 0.00% |
| Vanguard Capital Management LLC | 411,714 | 1.96% | $934.59K | +10,058 | 0.00% |
| Citadel Advisors LLC | 349,740 | 1.66% | $793.91K | +250,998 | 0.00% |
| Maven Securities LTD | 200,000 | 0.95% | $454.00K | New | 0.01% |
| Cantor Fitzgerald, L. P. | 200,000 | 0.95% | $454.00K | New | 0.00% |
| Birchview Capital, LP | 120,000 | 0.57% | $272.40K | +70,000 | 0.13% |
| Two Sigma Investments, LP | 96,890 | 0.46% | $219.94K | New | 0.00% |
| Jane Street Group, LLC | 89,442 | 0.43% | $203.03K | −77,655 | 0.00% |
| XTX Topco Ltd | 71,668 | 0.34% | $162.69K | +8,574 | 0.00% |
| Hrt Financial LP | 62,691 | 0.30% | $142 | New | 0.00% |
| Susquehanna International Group, Llp | 49,577 | 0.24% | $112.54K | New | 0.00% |
| BlackRock, Inc. | 37,535 | 0.18% | $85.21K | New | 0.00% |
| Rangeley Capital, LLC | 26,000 | 0.12% | $59.02K | New | 0.05% |
| Kestra Private Wealth Services, LLC | 23,000 | 0.11% | $52.21K | +10,000 | 0.00% |
| UBS Group AG | 16,777 | 0.08% | $38.08K | −9,524 | 0.00% |
| Fundamentum, LLC | 11,158 | 0.05% | $25.33K | New | 0.00% |
| Bnp Paribas Arbitrage, Snc | 10,500 | 0.05% | $23.84K | +3,400 | 0.00% |
| Scientech Research LLC | 10,184 | 0.05% | $23.12K | New | 0.02% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 33 | 4M | 18.8% | 10 / 12 | 4 / 11 | 1M | 1M |
| Q1 2026 | 34 | 4M | 20.3% | 18 / 6 | 4 / 5 | 2M | 2M |
| Q4 2025 | 22 | 4M | 20.6% | 6 / 6 | 1 / 4 | 1M | 0M |
| Q3 2025 | 20 | 4M | 17.6% | 2 / 4 | 4 / 2 | 0M | 0M |
| Q2 2025 | 20 | 4M | 18.1% | 4 / 3 | 7 / 1 | 0M | 0M |
| Q1 2025 | 17 | 4M | 19.1% | 3 / 5 | 7 / 1 | 2M | 0M |
| Q4 2024 | 15 | 2M | 9.9% | 14 / 0 | 1 / 0 | 1M | 0M |
| Q3 2024 | 1 | 1M | 4.6% | 1 / 0 | 0 / 0 | 1M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of GRCE | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 400,350 | 1.90% | $908.79K | 0.00% | Jun 30, 2026 |
| iShares Micro-Cap ETF | 35,188 | 0.17% | $79.88K | 0.01% | Jun 30, 2026 |
| Tiff Multi-Asset Fund | 16,239 | 0.08% | $36.86K | 0.00% | Jun 30, 2026 |
| Vanguard Balanced Index Fund | 11,364 | 0.05% | $25.80K | 0.00% | Jun 30, 2026 |
| Fidelity Nasdaq Composite Index Fund | 5,571 | 0.03% | $14.32K | 0.00% | May 31, 2026 |
| 1290 VT Micro Cap Portfolio | 2,347 | 0.01% | $5.33K | 0.00% | Jun 30, 2026 |
| Total Stock Market Index Trust | 778 | 0.00% | $1.77K | 0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Prashant Kohli | Chief Executive Officer, Director | 249,495 | 1.19% | Sep 10, 2026 |
| Amresh Kumar | VP Program Management | 66,712 | 0.32% | Sep 1, 2026 |
| Robert J. DelAversano | Principal Financial Officer | – | – | Sep 1, 2026 |
| R. Loch Macdonald | Chief Medical Officer | – | – | Sep 1, 2026 |
| Carrie D'Andrea | VP Clinical Operations | – | – | Apr 16, 2025 |
| A. Brian Davis | Director | – | – | Sep 21, 2026 |
| George Kottayil | Director | 3,462,884 | 16.46% | Sep 21, 2026 |
| Vimal Kavuru | Director | 4,258,305 | 20.24% | Sep 21, 2026 |
| Edward Neugeboren | Director | 37,895 | 0.18% | Sep 21, 2026 |
| Management Inc. Opaleye | 10% owner | 2,855,318 | 13.57% | Sep 23, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Management Inc. Opaleye 10% owner | Sep 23, 2026 | Buy | +5,318 | $2.10 | $11.17K | 2,855,318 |
| Management Inc. Opaleye 10% owner | Sep 21, 2026 | Buy | +9,771 | $2.10 | $20.52K | 2,850,000 |
| Prashant Kohli Chief Executive Officer, Director | Sep 9, 2026 | Buy | +100,000 | $2.14 | $214.00K | 121,357 |
| Management Inc. Opaleye 10% owner | Sep 9, 2026 | Buy | +5,836 | $2.09 | $12.20K | 2,775,229 |
| Management Inc. Opaleye 10% owner | Sep 8, 2026 | Buy | +9,393 | $2.10 | $19.73K | 2,769,393 |
| Management Inc. Opaleye 10% owner | Aug 14, 2026 | Buy | +11,608 | $2.09 | $24.26K | 2,760,000 |
| Vimal Kavuru Director, 10% owner | Sep 25, 2023 | Buy | +676,371 | $1.85 | $1.25M | 1,188,076 |
| Donald Olds Director | Aug 31, 2023 | Buy | +381 | $2.05 | $781 | 381 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.